Lam Research projects that revenue from its China end market will fall below 30% of total sales in fiscal 2026, down from approximately 35% in fiscal 2025, as U.S. export controls on advanced etch and deposition equipment weigh on shipments. Management indicated in its February earnings call that units sold into China could decline by roughly 15% year-over-year, trimming $450 million from revenues if market conditions do not improve. Analysts at Morgan Stanley have cut their 2026 revenue growth estimate to 10% from 14%, citing ongoing restrictions on high-NA lithography tools and the potential for further curbs on integrated circuit manufacturing capacity expansions in Shenzhen and Shanghai.

Despite headwinds in Greater China, Lam Research expects AI-driven capacity buildouts in the United States, Taiwan and South Korea to offset roughly 60% of the lost China revenue by mid-2026. The company has secured commitments for over 200 next-generation cluster tools from leading hyperscale operators, representing approximately $2.7 billion in order backlog. These systems are designed to support new wafer starts for high-bandwidth memory and advanced logic nodes at 3nm and below, which analysts at Goldman Sachs estimate could add 12 percentage points to Lam’s non-China growth rate in fiscal 2026.

Lam Research shares have climbed 188% over the past twelve months, driven in part by six distinct institutional inflows since September totaling an estimated $750 million in fresh capital. Data from EPFR Global shows that three semiconductor-focused ETFs allocated a combined $320 million to Lam between October and December, while two large pension funds and a sovereign wealth fund accounted for an additional $430 million in new positions by January. Portfolio managers cited the company’s leading market share in etch tools—currently around 45% globally—and its strong free cash flow conversion rate of 82% as key catalysts.

Lam Research’s core operating metrics remain robust, with a trailing-twelve-month gross margin of 51.3% and an operating margin near 28%. Consensus estimates from Bloomberg indicate adjusted EPS growth of 23% in fiscal 2026 and a return on invested capital of 18%. The company has also boosted its R&D spend to 14.8% of revenues, targeting next-generation atomic layer etch capabilities. With net debt at just 0.3 times trailing EBITDA and a board-approved $3 billion share-repurchase program in place, analysts believe Lam is well-positioned to sustain shareholder returns even if near-term China shipments remain constrained.